Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary

Subbiah Sivam, Dan R. Smith, Koji Takeuchi, Jau Shyong Hong

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Repeated administration of the antimanic drug lithium (4 mEq/kg/day for 2, 4 or 6 days, i.p.) to rats produced a progressive decline and eventual depletion of dynorphin-A (1-8) (DYN) concentration whereas Met5-enkephalin (ENK) was only marginally decreased in the neurointermediate lobe of the pituitary (NIL). Administration of a neuroleptic haloperidol neither affected ENK and DYN levels nor influenced lithium-induced changes. The study reveals that lithium produces a preferential perturbation in the dynorphin system relative to the enkephalin system. These results taken together with other evidence, indicate that dynorphin is possibly coreleased with vasopression following lithium administration and provide a pharmacological support to the previously described colocalization and corelease of these endogenous peptides in the NIL.

Original languageEnglish
Pages (from-to)291-298
Number of pages8
JournalNeuropeptides
Volume10
Issue number3
DOIs
StatePublished - 1987

Fingerprint

dynorphin (1-8)
Enkephalins
Haloperidol
Lithium
Rats
Dynorphins
Antimanic Agents
Antipsychotic Agents
Pharmacology
Peptides

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Clinical Neurology
  • Neuroscience(all)
  • Cellular and Molecular Neuroscience

Cite this

Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary. / Sivam, Subbiah; Smith, Dan R.; Takeuchi, Koji; Hong, Jau Shyong.

In: Neuropeptides, Vol. 10, No. 3, 1987, p. 291-298.

Research output: Contribution to journalArticle

@article{d205b3f563034054ba5ed435d648cb55,
title = "Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary",
abstract = "Repeated administration of the antimanic drug lithium (4 mEq/kg/day for 2, 4 or 6 days, i.p.) to rats produced a progressive decline and eventual depletion of dynorphin-A (1-8) (DYN) concentration whereas Met5-enkephalin (ENK) was only marginally decreased in the neurointermediate lobe of the pituitary (NIL). Administration of a neuroleptic haloperidol neither affected ENK and DYN levels nor influenced lithium-induced changes. The study reveals that lithium produces a preferential perturbation in the dynorphin system relative to the enkephalin system. These results taken together with other evidence, indicate that dynorphin is possibly coreleased with vasopression following lithium administration and provide a pharmacological support to the previously described colocalization and corelease of these endogenous peptides in the NIL.",
author = "Subbiah Sivam and Smith, {Dan R.} and Koji Takeuchi and Hong, {Jau Shyong}",
year = "1987",
doi = "10.1016/0143-4179(87)90079-5",
language = "English",
volume = "10",
pages = "291--298",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Lithium and haloperidol differentially alter the dynorphin A (1-8) and enkephalin levels in the neurointermediate lobe of rat pituitary

AU - Sivam, Subbiah

AU - Smith, Dan R.

AU - Takeuchi, Koji

AU - Hong, Jau Shyong

PY - 1987

Y1 - 1987

N2 - Repeated administration of the antimanic drug lithium (4 mEq/kg/day for 2, 4 or 6 days, i.p.) to rats produced a progressive decline and eventual depletion of dynorphin-A (1-8) (DYN) concentration whereas Met5-enkephalin (ENK) was only marginally decreased in the neurointermediate lobe of the pituitary (NIL). Administration of a neuroleptic haloperidol neither affected ENK and DYN levels nor influenced lithium-induced changes. The study reveals that lithium produces a preferential perturbation in the dynorphin system relative to the enkephalin system. These results taken together with other evidence, indicate that dynorphin is possibly coreleased with vasopression following lithium administration and provide a pharmacological support to the previously described colocalization and corelease of these endogenous peptides in the NIL.

AB - Repeated administration of the antimanic drug lithium (4 mEq/kg/day for 2, 4 or 6 days, i.p.) to rats produced a progressive decline and eventual depletion of dynorphin-A (1-8) (DYN) concentration whereas Met5-enkephalin (ENK) was only marginally decreased in the neurointermediate lobe of the pituitary (NIL). Administration of a neuroleptic haloperidol neither affected ENK and DYN levels nor influenced lithium-induced changes. The study reveals that lithium produces a preferential perturbation in the dynorphin system relative to the enkephalin system. These results taken together with other evidence, indicate that dynorphin is possibly coreleased with vasopression following lithium administration and provide a pharmacological support to the previously described colocalization and corelease of these endogenous peptides in the NIL.

UR - http://www.scopus.com/inward/record.url?scp=0023428548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023428548&partnerID=8YFLogxK

U2 - 10.1016/0143-4179(87)90079-5

DO - 10.1016/0143-4179(87)90079-5

M3 - Article

C2 - 2891076

AN - SCOPUS:0023428548

VL - 10

SP - 291

EP - 298

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 3

ER -